Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biodyn LSE:OBD London Ordinary Share GB00BD5H8572 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.875p -1.09% 260.125p 257.25p 263.00p 263.00p 263.00p 263.00p 33,167 16:35:12
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.1 -2.1 -2.1 - 223.96

Oxford Biodyn Share Discussion Threads

Showing 51 to 73 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
11/10/2017
08:32
And more new out on ALS ... they seem to be onto something here ...
catsick
06/10/2017
04:45
Impressive indeed.
mirabeau
06/10/2017
02:06
Yes its another vulpes holding, vulpes fund is up over 100pct this year even without this nice little performer, Steve in the past though has made 1000's of percent returns in the artradis fund which he shut down after they called the credit crisis bang on ..... I think he cares more about curing cancer though now but the potential returns on some of these companies at the bleeding edge wont hurt..
catsick
05/10/2017
15:26
Looking alright! :) Thanks for the heads up on OXB Catsick
ph1ts
28/9/2017
12:41
Reading up a little on how huge the number of false positives from mammograms is and how dangerous the use of them is as well as the failure to pick up early a lot of cancer this could really be a massive breakthrough
catsick
28/9/2017
09:33
This would seem to indicate they have a very effective way of finding cancers quickly without the need for lots of breast fondling by gps ... could be revolutionary if replaces current practice cheaply
catsick
28/9/2017
09:11
It does seem remarkably prescient, quite a move
shoee62
28/9/2017
08:01
Interesting trading a couple of day prior to the announcement. Presumably the authorities are looking very closely into this.
saul goodman
28/9/2017
07:17
Interesting news on the breast cancer front, could be very useful indeed ....
catsick
10/7/2017
13:50
That's why it's so strange........being "backed by Vulpes" is normally the kiss of death...
badger60
06/7/2017
14:59
Well they both are backed by vulpes so from the same stable of promising oxford univ biotech spinoffs..
catsick
06/7/2017
10:48
looks like it might be leaky, like it's near namesake OXB.
shoee62
05/7/2017
15:39
'ello What's all this going on 'ere then?
saul goodman
18/5/2017
08:53
Today's RNS.... potential undisclosed milestone payments and royalties from someone who may potentially use the product. Another bottom drawer dust gathering deal which as of today is starting it's journey into obscurity. .......
badger60
27/4/2017
13:16
Seem many remember Hoyer Millar from ONP days.... The OBDL tech has clinical appeal, but hard to see where this is going to go while led by unprofessional with poor track record ..... Usual soundbites and non performance... 30m hole in mkt cap already... odey picked well
greaves7
23/2/2017
15:56
Oh dear!'ere we go EpiFit!......... another non cash generative agreement which will doubtless disappear into obscurity. No specific details, timescales, revenues etc...... just soundbites.Hire a fluffy advisor .......so that you can say that you've got one.Welcome to Proteome Sciences revisited.....Oh dear!
badger60
02/2/2017
13:43
I've got 20 mio quids worth of old rope just begging to be bought..........
badger60
02/2/2017
13:33
Indeed. Although it will be massively overvalued even then. I do not know how they can possibly have got the IPO away at the price they did. Fair play to them!
golly blackwell
02/2/2017
13:26
Most probably 50p
1lilac
02/2/2017
10:49
There's a very good chance that this POS will be well below a quid a share before the month is out.Looking at Hoyer Millar's mug shot in the newspaper, it looks like that he's already spent his windfall on a few kgs of Columbia's finest. I wonder what Diggle has spent his on..........buying a few more PRM shares, I suppose?
badger60
02/2/2017
10:18
https://www.youtube.com/watch?v=CZXLLMbJdZ4
golly blackwell
31/1/2017
14:57
Yep.....It certainly looks like the bod could be starting to enjoy more of the good life as the exes spiral in an upward direction. I hope that there are no contentious doubts over handling of the company accounts, as there were in Hoyer Millar's last commercial biotech venture which went bankrupt.
badger60
31/1/2017
12:39
Not long now before sub £1.00 ps. With no tangible assets of value, sterile MOUs can drag on for years. They will milk the cashburn for all it's worth and pass the begging bowl around again, issuing the odd upbeat RNs to mug Investors, once the £7mio has dried up.Not a bad little £20mio earner for the founding partners, which has lost circa 20% for the mug cash investors in less that 2 months since it came to the market.
badger60
Chat Pages: 3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20171019 23:50:24